DalsnaFinance › IPOs › Viking Therapeutics › IPO
Viking Therapeutics, Inc. completed its initial public offering on NASDAQ on April 29, 2015, pricing at $8.00 a share.
| Ticker | VKTX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | April 29, 2015 |
| Offering price | $8.00 |
| Shares offered | 3,000,000 |
| Total raised | $24M |
Viking Therapeutics, Inc. sold 3,000,000 shares at $8.00 each on NASDAQ. Multiplied out, that is $24 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $24 million total recorded for the deal.
Viking Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Viking Therapeutics, Inc.. This page is general information, not investment advice.